HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Thomas E Witzig Selected Research
Thomas E Witzig Research Topics
Disease
84
Neoplasms (Cancer)
05/2024 - 02/2002
65
Lymphoma (Lymphomas)
05/2024 - 01/2002
63
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2023 - 01/2002
38
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
05/2022 - 07/2007
35
Multiple Myeloma
01/2021 - 11/2002
26
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2024 - 06/2002
19
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
11/2023 - 05/2005
19
Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2022 - 01/2002
18
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
04/2024 - 11/2002
13
Disease Progression
01/2020 - 09/2002
12
Infections
05/2024 - 06/2002
12
Hodgkin Disease (Hodgkin's Disease)
01/2024 - 10/2005
12
Immunoglobulin Light-chain Amyloidosis
06/2014 - 02/2003
11
B-Cell Lymphoma (Lymphoma, B Cell)
04/2024 - 01/2002
10
Thrombocytopenia (Thrombopenia)
08/2017 - 06/2002
7
Neutropenia
05/2022 - 01/2007
5
Fatigue
05/2022 - 04/2005
5
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 04/2003
5
Colonic Neoplasms (Colon Cancer)
03/2007 - 09/2003
4
Acute Kidney Injury (Acute Renal Failure)
02/2024 - 09/2021
4
Febrile Neutropenia
05/2022 - 07/2005
4
Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 07/2006
4
Immunoglobulin G4-Related Disease
12/2018 - 06/2015
4
Anemia
08/2017 - 01/2003
4
Necrosis
01/2017 - 10/2003
4
Smoldering Multiple Myeloma
01/2016 - 08/2004
4
Paraproteinemias (Monoclonal Gammopathy)
12/2012 - 01/2002
4
Autoimmune Diseases (Autoimmune Disease)
01/2011 - 09/2003
4
Carcinoma (Carcinomatosis)
03/2007 - 05/2002
3
Sepsis (Septicemia)
04/2021 - 06/2002
3
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2018 - 09/2007
3
T-Cell Lymphoma (Lymphoma, T Cell)
07/2015 - 10/2009
3
Genetic Translocation (Chromosomal Translocation)
01/2015 - 09/2013
3
POEMS Syndrome (Syndrome, POEMS)
07/2013 - 04/2003
3
Chromosome Aberrations (Chromosome Abnormalities)
02/2011 - 05/2003
3
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
04/2008 - 06/2004
2
COVID-19
04/2024 - 06/2023
2
Diarrhea
05/2022 - 03/2013
Drug/Important Bio-Agent (IBA)
53
Rituximab (Mabthera)
FDA Link
01/2024 - 01/2002
24
Lenalidomide (CC 5013)
FDA Link
01/2022 - 01/2007
23
Proteins (Proteins, Gene)
FDA Link
04/2024 - 04/2003
21
ibritumomab tiuxetan (Zevalin)
FDA Link
01/2023 - 02/2002
16
Dexamethasone (Maxidex)
FDA Link
Generic
11/2018 - 11/2002
13
Cytokines
IBA
04/2024 - 08/2004
11
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2021 - 08/2011
11
TOR Serine-Threonine Kinases
IBA
01/2019 - 08/2005
11
Everolimus
FDA Link
10/2018 - 07/2006
10
Immunoglobulin M (IgM)
IBA
01/2020 - 01/2002
10
Monoclonal Antibodies
IBA
10/2008 - 08/2003
9
Biomarkers (Surrogate Marker)
IBA
07/2022 - 12/2006
8
Methotrexate (Mexate)
FDA Link
Generic
02/2024 - 06/2004
8
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2021 - 12/2005
8
Immunoglobulins (Immunoglobulin)
IBA
11/2018 - 04/2006
8
Thalidomide (Thalomid)
FDA Link
10/2010 - 11/2002
7
Yttrium-90
IBA
01/2023 - 08/2002
7
Prednisone (Sone)
FDA Link
Generic
01/2021 - 10/2011
7
Yttrium
IBA
07/2013 - 02/2002
6
ibrutinib
IBA
10/2021 - 01/2017
6
Vincristine (Oncovin)
FDA Link
Generic
01/2021 - 12/2005
6
Cyclin D1
IBA
10/2020 - 08/2005
6
Bortezomib (Velcade)
FDA Link
01/2020 - 07/2005
6
Mechanistic Target of Rapamycin Complex 1
IBA
10/2018 - 10/2009
6
temsirolimus
FDA Link
04/2011 - 08/2005
5
Anthracyclines
IBA
04/2024 - 08/2014
5
B-Cell Activating Factor
IBA
05/2009 - 02/2006
4
Anti-Bacterial Agents (Antibiotics)
IBA
05/2024 - 06/2002
4
Immune Checkpoint Inhibitors
IBA
01/2024 - 03/2016
4
DNA (Deoxyribonucleic Acid)
IBA
01/2022 - 09/2006
4
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
01/2019 - 07/2006
4
Ligands
IBA
01/2017 - 02/2008
4
Sirolimus (Rapamycin)
FDA Link
03/2012 - 07/2006
4
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
03/2012 - 08/2004
4
MTOR Inhibitors
IBA
04/2011 - 10/2009
4
CD20 Antigens
IBA
03/2008 - 01/2006
3
Messenger RNA (mRNA)
IBA
01/2023 - 08/2005
3
Bendamustine Hydrochloride
FDA Link
01/2022 - 08/2018
3
Interferons
IBA
01/2022 - 09/2012
3
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
04/2021 - 03/2007
3
Troponin
IBA
01/2019 - 09/2004
3
Steroids
IBA
12/2018 - 03/2008
3
Immunoglobulin G (IgG)
IBA
04/2016 - 03/2008
3
Alemtuzumab (Campath)
FDA Link
01/2015 - 08/2003
3
Complement System Proteins (Complement)
IBA
09/2012 - 10/2008
3
Vitamin D
FDA Link
Generic
07/2012 - 09/2010
3
Interleukin-12 (IL 12)
IBA
04/2012 - 01/2002
3
Interleukin-10 (Interleukin 10)
IBA
03/2012 - 10/2009
3
Interleukin-6 (Interleukin 6)
IBA
11/2011 - 10/2003
3
Adrenal Cortex Hormones (Corticosteroids)
IBA
09/2010 - 05/2003
3
Phosphotransferases (Kinase)
IBA
08/2008 - 05/2003
2
Biological Factors
IBA
01/2024 - 09/2012
2
Radioisotopes (Radionuclides)
IBA
08/2023 - 07/2011
2
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
12/2022 - 11/2012
Therapy/Procedure
89
Therapeutics
05/2024 - 01/2002
27
Radioimmunotherapy
01/2024 - 02/2002
23
Drug Therapy (Chemotherapy)
01/2022 - 06/2002
11
Stem Cell Transplantation
01/2022 - 12/2002
8
Radiotherapy
05/2024 - 12/2003
7
Aftercare (After-Treatment)
02/2024 - 04/2003
6
Immunotherapy
01/2024 - 05/2002
3
Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
04/2006 - 05/2004